The FDA commits $16M to track prescription drug use

The FDA has set aside $16 million for tracking which drugs are used, in what combinations and for how long, Regulatory Focus reports. Source Healthcare Analytics is supporting the initiative, data from which FDA will incorporate into its epidemiological drug safety research program. Article